Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-004952
Filing Date
2022-02-14
Accepted
2022-02-14 16:06:25
Documents
48
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q onvo-10q_20211231.htm   iXBRL 10-Q 1967454
2 EX-31.1 onvo-ex311_8.htm EX-31.1 9210
3 EX-31.2 onvo-ex312_7.htm EX-31.2 9446
4 EX-32.1 onvo-ex321_6.htm EX-32.1 8938
  Complete submission text file 0001564590-22-004952.txt   5364905

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA onvo-20211231.xsd EX-101.SCH 34302
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onvo-20211231_cal.xml EX-101.CAL 32744
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onvo-20211231_def.xml EX-101.DEF 93106
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE onvo-20211231_lab.xml EX-101.LAB 280479
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onvo-20211231_pre.xml EX-101.PRE 210597
42 EXTRACTED XBRL INSTANCE DOCUMENT onvo-10q_20211231_htm.xml XML 763788
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 22631487
SIC: 2836 Biological Products, (No Diagnostic Substances)